“Costs and Efficacy Ofolanzapine and Risperidone in Schizophrenia”. Farmeconomia. Health Economics and Therapeutic Pathways 8, no. 2 (June 15, 2007): 53–60. Accessed February 15, 2026. https://journals.seedstm.com/index.php/FE/article/view/241.